Dienogest
- Level
- Commodity
- Parent
- 51351600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51351606This classification denotes a therapeutic progestin with the molecular formula C20H25NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 46M3EV8HHE, chemically known as 19-norpregna-4,9-diene-21-nitrile, 17-hydroxy-3-oxo-, (17-alpha)- but generally known as dienogest, which bears US NIH Compound Identifier 68861. European Medicines Agency schedules Dienogest in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07108MIG. The term DIENOGEST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). DIENOGEST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dienogest under HS 29372300 and SITC 54153. As of Q4 2014, DIENOGEST remains the US FDA Preferred Term for this commodity. Dienogest bears US NLM identifiers UMLS ID C0057916 and NCI Concept Code C87238. SMILES: OC1(C2(C(C3C(=C4C(=CC(=O)CC4)CC3)CC2)CC1)C)CC#N.
Same parent
Under 51351600 · 35Activities that produce or sell this
KBLI · 8Inherited from family 51350000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.